TENDER AND SUPPORT AGREEMENTTender and Support Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
TENDER AND SUPPORT AGREEMENT (this “Agreement”) dated as of January 11, 2015 by and among Roche Holdings, Inc., a Delaware corporation (the “Investor”), and the entity listed on Schedule A hereto (the “VC Shareholder”).
INVESTOR RIGHTS AGREEMENT dated as of January 11, 2015 among FOUNDATION MEDICINE, INC., ROCHE HOLDINGS, INC. and THE OTHER STOCKHOLDERS PARTY HERETO (FOR THE LIMITED PURPOSES SET FORTH HEREIN)Investor Rights Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
INVESTOR RIGHTS AGREEMENT (this “Agreement”) dated as of January 11, 2015 among Foundation Medicine, Inc., a Delaware corporation (the “Company”), Roche Holdings, Inc., a Delaware corporation (the “Investor”), and, solely for the purposes of Section 2.02(f), Section 6.03(a) and Section 6.04 hereof, the stockholders listed on the signature pages hereto under the heading “Existing VC Investors” (each, an “Existing VC Investor”).
TRANSACTION AGREEMENT dated as of January 11, 2015 between ROCHE HOLDINGS, INC. and FOUNDATION MEDICINE, INC.Transaction Agreement • January 12th, 2015 • Foundation Medicine, Inc. • Services-medical laboratories • Delaware
TRANSACTION AGREEMENT (this “Agreement”) dated as of January 11, 2015 between Roche Holdings, Inc., a Delaware corporation (the “Investor”), and Foundation Medicine, Inc., a Delaware corporation (the “Company”).
